Pillway secured a substantial investment of $9.5 million from Sun Life

November 28, 2023

Pillway, a leading digital pharmacy in Canada, has secured a substantial investment of $9.5 million from Sun Life, with the potential for an additional $1.5 million. The funding aims to fuel Pillway’s mission of revolutionizing healthcare services through the integration of cutting-edge technology and personalized care.

This partnership signifies a significant step towards reshaping how individuals manage their health, with an emphasis on convenience, efficiency, and tailored healthcare. The substantial funding from Sun Life, amidst a competitive landscape in the HealthTech sector, underscores a strong endorsement of Pillway’s unique value proposition and its pivotal role in the future of pharmacy care.

Lak Gill, CEO of Pillway, expressed the significance of Sun Life’s investment, stating that it goes beyond mere financial support. Gill emphasized the strengthening of a partnership that has already made a tangible impact on people’s lives. The funding is poised to accelerate Pillway’s growth, enhancing its capacity to deliver personalized, technology-driven, and patient-centric healthcare solutions.

LaBarge Weinstein acted as counsel to Pillway with a team that included Kyle Lavendar, Gisele Salazar, Stephanie Benedict and Raj Oberoi.